Congressional Republicans assert FDA lacks adequate insight into the drug supply chain to avert potential drug shortages, saying the agency is not doing enough to scrutinize foreign companies that provide pharmaceuticals to the United States, while Democrats, like FDA, argue the agency needs more authority to address the problem . At a House Energy & Commerce oversight panel hearing Thursday (May 11), subcommittee Chair Morgan Griffith (R-VA) said FDA has often “made drug shortages worse and left us more vulnerable.”...